Agilent Technologies (A) Stock Forecast & Price Target

$114.67 +0.69 (+0.60%)

As of 03:19 PM Eastern

Agilent Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 13 Analyst Ratings

Sell
0

Hold
6

Buy
7

Based on 13 Wall Street analysts who have issued ratings for Agilent Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 13 analysts, 6 have given a hold rating, and 7 have given a buy rating for A.

Consensus Price Target

$139.77
21.89% Upside

According to the 13 analysts' twelve-month price targets for Agilent Technologies, the average price target is $139.77. The highest price target for A is $165.00, while the lowest price target for A is $116.00. The average price target represents a forecasted upside of 21.89% from the current price of $114.67.

Get the Latest News and Ratings for A and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Agilent Technologies and its competitors.

A Analyst Ratings Over Time

Type	Current Forecast 8/8/24 to 8/8/25	1 Month Ago 7/9/24 to 7/9/25	3 Months Ago 5/10/24 to 5/10/25	1 Year Ago 8/9/23 to 8/8/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	9 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	7 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$139.77	$139.77	$143.00	$138.06
Forecasted Upside	21.89% Upside	15.06% Upside	33.73% Upside	0.97% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Hold	Moderate Buy

A Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

A Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Agilent Technologies Stock vs. The Competition

Type	Agilent Technologies	Medical Companies	S&P 500
Consensus Rating Score	2.54	2.81	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	22.74% Upside	28,357.18% Upside	14.10% Upside
News Sentiment Rating	Positive News See Recent A News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/8/2025	Evercore ISI 3 of 5 stars	Vijay Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	In-Line ➝ In-Line	$125.00 ➝ $130.00	+9.05%
6/24/2025	Barclays 3 of 5 stars	L. Sergott Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$115.00 ➝ $125.00	+6.38%
5/30/2025	Leerink Partners 1 of 5 stars		Boost Target	Buy	$135.00	+19.78%
5/29/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Elizabeth Garcia Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$150.00 ➝ $130.00	+13.99%
5/29/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tycho Peterson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$160.00 ➝ $155.00	+34.39%
5/29/2025	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$150.00	+29.52%
5/22/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Catherine Schulte Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$159.00 ➝ $140.00	+28.35%
4/21/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$135.00 ➝ $116.00	+16.44%
4/17/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$155.00 ➝ $135.00	+31.59%
12/19/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy	$165.00	+23.96%
Get the Latest News and Ratings for A and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.
12/13/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$153.00 ➝ $150.00	+8.93%
11/26/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Market Perform ➝ Market Perform	$140.00 ➝ $135.00	+1.41%
8/26/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy	$151.00	+7.19%
6/27/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Schenkel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Peer Perform
3/26/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$67.00 ➝ $90.00	-38.30%
12/7/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$128.00 ➝ $145.00	+12.47%
8/16/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$160.00 ➝ $150.00	+19.38%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 03:09 PM ET.

Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, August 7, 2025. Please send any questions or comments about these Agilent Technologies pros and cons to contact@marketbeat.com.

Agilent Technologies
Bull Case

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

The company reported earnings per share of $1.31 for the latest quarter, exceeding analyst expectations, which indicates strong financial performance and effective management.
Agilent Technologies, Inc. has shown a revenue increase of 6.0% compared to the same quarter last year, suggesting growth in its market and product demand.
The current stock price is around $117, reflecting a stable investment opportunity in the medical research sector.
With a net margin of 17.59% and a return on equity of 25.92%, the company demonstrates efficient operations and profitability, which are attractive metrics for investors.
The firm has a moderate dividend yield of 0.9% with a payout ratio of 24.44%, indicating a commitment to returning value to shareholders while maintaining sufficient reinvestment in the business.

Agilent Technologies
Bear Case

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

Recent analyst ratings show a mix of hold and buy ratings, with some analysts reducing their price targets, which may indicate uncertainty about future stock performance.
The company’s stock has experienced fluctuations, and while it has shown growth, the potential for volatility could deter risk-averse investors.
Insider selling, such as the CEO's recent sale of shares, may raise concerns about the company's future prospects and management's confidence in its performance.
Despite positive earnings, the competitive landscape in the medical research sector is intense, which could impact Agilent Technologies, Inc.'s market share and growth potential.
The dividend yield, while positive, is relatively low compared to other investment opportunities, which may not attract income-focused investors.

A Forecast - Frequently Asked Questions

: According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Agilent Technologies is $139.77, with a high forecast of $165.00 and a low forecast of $116.00.
: 13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 6 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" A shares.
: According to analysts, Agilent Technologies's stock has a predicted upside of 21.89% based on their 12-month stock forecasts.
: Agilent Technologies has been rated by research analysts at Barclays, Evercore ISI, JPMorgan Chase & Co., Leerink Partners, Robert W. Baird, TD Cowen, and UBS Group in the past 90 days.
: Analysts like Agilent Technologies less than other "medical" companies. The consensus rating score for Agilent Technologies is 2.54 while the average consensus rating score for "medical" companies is 2.81. Learn more on how A compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:A) was last updated on 8/8/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilent Technologies (A) Stock Forecast & Price Target